Select your language/region

News & events

Press release

2026/08/10

Q-linea Announces ASTar® Contract With Large Health System in the U.S. Mid-Atlantic Region

Regulatory press release

2026/07/10

Interim report January 1 - June 30 2026
FDA decision sets up for growth in U.S. FDA clearance for expanded U.S. menu combined with encouraging progress across...
Read more >

Regulatory press release

2026/05/29

Annika Blondeau Henriksson new interim CFO
Q-linea AB (publ) (OMX: QLINEA) today announces that the company has hired Annika Blondeau Henriksson as CFO and IR....
Read more >

Regulatory press release

2026/05/27

BULLETIN FROM ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)

Regulatory press release

2026/04/30

Interim report January - March 2026
Growing recurring income and increased market activity within rapid ASTFirst quarter: 1 January–31 March 2026Income from sales of consumables...
Read more >

Regulatory press release

2026/04/27

NOTICE OF ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)

Regulatory press release

2026/04/24

Q-linea publish the Annual report for 2025
Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), announced today that the Annual Report for the 2025 fiscal year has been...
Read more >

Regulatory press release

2026/04/16

Q-linea announces FDA clearance of expanded ASTar blood testing menu

Press release

2026/04/02

Q-linea announces shipment of two ASTar® instruments to Saudi Arabia
Load more